10% of diabetics have non-healing wounds that are frequently infected by drug-resistant bacteria. 1% of diabetics with chronic wounds need limb amputation due to bacterial infection. Existing wound infection management strategies mainly relay on antibiotics that are inefficient towards drug-resistant bacteria and silver-based wound dressings that inactivate bacteria only partially, often cause skin irritation and delay wound healing.
Nanordica Medical OÜ has developed a nanoformula enabling to create 5x more efficient antibacterial wound dressings compared to the existing market alternatives.
Nanoformula Icon
Unique antibacterial nanoformula
5x Icon
5x more efficient antibacterial effect compared to traditional silver
Drug-resistant Icon
Effective against drug-resistant bacteria
Wound Healing Icon
Supports wound healing
Environmentally Friendly Icon
Environmentally friendly
Multifunctional Icon
Multifunctional: can be used in wound dressings, sprays, on surfaces
Nanordica nanoformula has proven antibacterial efficiency confirmed by North Estonia Medical Centre. Nanoformula can be used to create a wide range of antibacterial products like wound dressings, sprays, creams, catheters or surface coatings. Currently we focus on the development of advanced antibacterial wound dressings. We already developed lab prototypes of wound dressings, established contract manufacturing and got positive feedback from medical doctors and patients. In Q1 2021 we will submit patent application to protect the technology.
Advanced Antibacterial Wound Dressings
Nanofibers produced by electrospinning, an easy, cost-effective and scalable process
Skin contact layer with electrospun nanofibers has large surface area, porosity and controlled release of antibacterial nanoformula into wound environment
Provides efficient inactivation of bacteria and supports wound healing
Development Stage
Stage I — Completed
Research & development
Antibacterial nanoformula Lab prototypes In vitro efficiency IP requirements
Stage II — Ongoing
Industrial prototypes, IP, product-market fit
IP protection Industrial manufacturing In vitro and in vivo testing Product-market fit Validated business model
Stage III
Documentation Regulations Partnering with pharmaceutical company Commercialization

For investors

We are raising investments. Contact us for further information.
For partners

We are interested in partners from pharmaceutical companies.
Anna-Liisa Kubo

Over 10 years of experience in R&D and industry.
Olesja Bondarenko

Over 10 years experience in leading research projects.
Grigory Vasiliev

A specialist in infectious diseases. Collaboration with hospitals.

About Nanordica
Nanordica Medical OÜ is a healthtech startup developing advanced antibacterial products. Our competitive edge is our unique technology, a mixture of antibacterial nanoparticles (nanoformula) that was developed as a result of over 10 years of research. Our technology potentiates silver, the „gold standard“ antibacterial agent currently used in medical devices, enabling to achieve superior antibacterial effect. Our first product are antibacterial wound dressings for advanced wound healing of infected chronic wounds. We have produced laboratory prototypes, established contract manufacturing and settled feedback loop with the hospitals for the customer’s needs.
Nanordica Medical is a spin-off of the National Institute of Chemical Physics and Biophysics (Estonia).
© 2021 Nanordica Medical OÜ
Register code: 14710113
Billing adress: Vana-Lõuna tn 39a-7, Tallinn, Harjumaa 10134